ScholarLens Back to search
2010•Heilongjiang Medical JournalRequires access

Clininal Effect of Batroxobin in Treating 42 Cases with Acute Cerebral Infarction

Lin Che

Open publisher page 0 citations

Abstract

Objective To evaluate the safety and effectiveness of Batroxobin in treating acute cerebral infarction.Methods All patients were randomly divided into treatment group and control group,each group have 42 cases respectively.In addition to conventional treatment,treatment group was added Batroxobin,while control group Shuxuetong.Clinical assessment index include the degree of neurological deficit scores and plasma fibrinogen determination.Results Compared with control group,treatment group Batroxobin plasma fibrinogen levels were significantly lower(P0.01).After 30 days treatment,total clinical effect has significant difference(P0.05).Conclusion Treating acute cerebral infarction by Batroxobin is effective and relatively safe,and short-term effect might be sure.

About this research paper

What this paper is about

Objective To evaluate the safety and effectiveness of Batroxobin in treating acute cerebral infarction.Methods All patients were randomly divided into treatment group and control group,each group have 42 cases respectively.In addition to conventional treatment,treatment group was added Batroxobin,while control group Shuxuetong.Clinical assessment index include the degree of neurological deficit scores and plasma fibrinogen determination.Results Compared with control group,treatment group Batroxobin plasma fibrinogen levels were significantly lower(P0.01).After 30 days treatment,total clinical effect has significant difference(P0.05).Conclusion Treating acute cerebral infarction by Batroxobin is effective and relatively safe,and short-term effect might be sure.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the safety and effectiveness of Batroxobin in treating acute cerebral infarction.Methods All patients were randomly divided into treatment group and control group,each group have 42 cases respectively.In addition to conventional treatment,treatment group was added Batroxobin,while control group Shuxuetong.Clinical assessment index include the degree of neurological deficit scores and plasma fibrinogen determination.Results Compared with control group,treatment group Batroxobin plasma fibrinogen levels were significantly lower(P0.01).After 30 days treatment,total clinical effect has significant difference(P0.05).Conclusion Treating acute cerebral infarction by Batroxobin is effective and relatively safe,and short-term effect might be sure.

Key concepts: Batroxobin, Medicine, Fibrinogen, Cerebral infarction, Anesthesia, Significant difference, Surgery, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clininal Effect of Batroxobin in Treating 42 Cases with Acute Cerebral Infarction — Research Paper | ScholarLens